Highlights

Get the latest viral hepatitis and NASH data with rapid Capsule Summaries and downloadable slidesets covering key studies from Vienna.

Share

Program Content

Activities

  • Highlights
    Highlights From EASL 2019
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 30, 2019

    Expires: April 28, 2020

  • NAFLD/NASH Audio
    Key NAFLD/NASH Studies Influencing My Practice Following EASL 2019
    Audio
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 02, 2019

    Expires: April 30, 2020

  • Viral Hepatitis Audio
    Key Viral Hepatitis Studies Influencing My Practice Following EASL 2019
    Audio
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 10, 2019

    Expires: May 08, 2020

Activities

STOP
STOP Study: Incidence and Predictors of ALT Flares in HBeAg-Negative Patients Discontinuing NA Therapy for CHB
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2019

Expires: April 13, 2020

HCV/HBV Test-and-Treat
Pilot Study of Same-Day Testing and Treatment of HCV and HBV in Egyptian Village
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2019

Expires: April 13, 2020

US HCV Care Cascade
Retrospective Analysis Identifies Numerous Gaps Along HCV Care Cascade Across Physician Specialties in the US
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2019

Expires: April 13, 2020

ETHOS Engage
ETHOS Engage Study: Uptake of HCV Testing and Treatment Among People Who Inject Drugs in Australia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2019

Expires: April 13, 2020

SMART-C
SMART-C: Standard vs Simplified Monitoring of Initial HCV Treatment With Glecaprevir/Pibrentasvir
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2019

Expires: April 13, 2020

English HCV Registry
Efficacy of HCV Treatment in a Large Clinical Cohort From the English National HCV Registry
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2019

Expires: April 14, 2020

REGENERATE
Interim Analysis of Phase III REGENERATE: Obeticholic Acid vs Placebo for NASH
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 16, 2019

Expires: April 14, 2020

Emricasan NASH Cirrhosis and Portal Hypertension
Phase II Trial of Emricasan in NASH Cirrhosis and Severe Portal Hypertension
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2019

Expires: April 15, 2020

HCC Risk With TDF vs ETV in CHB
Lower Risk of Hepatocellular Carcinoma With TDF vs ETV in Patients With Chronic Hepatitis B From Large Hong Kong Database Analysis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 17, 2019

Expires: April 15, 2020

VK2809 in NAFLD
Randomized Phase II Trial of VK2809, an Investigational Thyroid Hormone Receptor Agonist, vs Placebo in NAFLD With Hyperlipidemia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2019

Expires: April 20, 2020

Faculty

cover img faculity

Nancy Reau, MD

Associate Professor of Medicine
Center for Liver Disease
University of Chicago
Chicago, Illinois

cover img faculity

Zobair M. Younossi, MD, MPH, FACP, FACG

Executive Director, Center for Liver Diseases
Inova Fairfax Hospital
Executive Director of Research
Inova Health System
Professor of Medicine
Virginia Commonwealth University, Inova Campus
Annandale, Virginia

cover img faculity

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

ProCE Banner

Supporters

AbbVie

Gilead